In vitro antileukaemic activity of extracts from chokeberry (Aronia melanocarpa [Michx] Elliott) and mulberry (Morus alba L.) leaves against sensitive and multidrug resistant HL60 cells

Phytotherapy Research

Volumn 22, Issue 5, 2008, Pages 689-694

  Skupień, Katarzyna ^a   Kostrzewa Nowak, Dorota ^b   Oszmiański, Jan ^c   Tarasiuk, Jolanta ^b  

^a WEST POMERANIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF SZCZECIN   (Poland)

^c WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

Berry plants; Human promyelocytic HL60 cells; in vitro antileukaemic activity; Leaf extracts; Multidrug resistance MDR; Phenolic compounds

Indexed keywords

ANTINEOPLASTIC AGENT; ARONIA MELANOCARPA EXTRACT; GLYCOPROTEIN P; HERBACEOUS AGENT; MORUS ALBA EXTRACT; MULTIDRUG RESISTANCE PROTEIN 1;

ANTINEOPLASTIC ACTIVITY; ARONIA MELANOCARPA; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CULTURE; CELL STRAIN HL 60; CONCENTRATION (PARAMETERS); DRUG SENSITIVITY; EXTRACTION AND EXTRACTS; GENE OVEREXPRESSION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MULBERRY; MULTIDRUG RESISTANCE; PHENOTYPE; STATISTICAL ANALYSIS;

CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESISTANCE, MULTIPLE; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MORUS; PHOTINIA; PLANT EXTRACTS; PLANT LEAVES;

MORUS (PLANT); MORUS ALBA; PHOTINIA; PHOTINIA MELANOCARPA;

EID: 44149091682     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2411     Document Type: Article

References (31)

1. Bandyopadhyay G, Biswas T, Roy KC et al. 2004. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104: 2514-2522.
2. Chaudhary PM, Roninson LB. 1993. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Nat Cancer Inst 85: 632-639.
3. Chiang LC, Ng LT, Chiang W. 2003. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Med 69: 600-604.
4. 2 and cytokines in RAW264.7 macrophages. Fitoterapia 76: 608-613.
5. Enkhmaa B, Shiwaku K, Katsube T et al. 2005. Mulberry (Morus alba L.) leaves and their major flavonol quercetin 3(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J Nutr 135: 729-734.
6. Fernandes J, Castilho RO, da Costa MR, Wagner-Souza K, Coelho Kaplan MA, Gattass CR. 2003. Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett 20: 165-169.
7. Fukai T, Kaitou K, Terada S. 2005. Antimicrobial activity of 2-arylbenzofurans from Morus species against methicillin-resistant Staphylococcus aureus. Fitoterapia 76: 708-711.
8. Hibasami H, Esaki H, Kataoka T, Takaue S, Kawakishi S. 2003. Human stomach cancer cells undergo apoptosis by genistein, but not other genistein- and daidzein-related compounds. J Herbs Spices Med Plants 10: 39-48.
9. Hollman PCH, Hertog MGL, Katan MB. 1996. Analysis and health effects of flavonoids. Food Chem 57: 43-46.
10. Kang TB, Liang NC. 1997. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54: 1013-1018.
11. Kostrzewa-Nowak D, Paine MJI, Korytowska A et al. 2007. Bioreductive activation of mitoxantrone by NADPH cytochrome P450 reductase. Implications for increasing its ability to inhibit the growth of sensitive and multidrug resistant leukaemia HL60 cells. Cancer Lett 245: 252-262.
12. Kostrzewa-Nowak D, Paine MJI, Wolf CR, Tarasiuk J. 2005. The role of bioreductive activation of doxorubicin in its cytotoxic activity against leukaemia HL60 sensitive cell line and its multidrug resistant sublines. Br J Cancer 93: 89-97.
13. Krishnamachary N, Center MS. 1993. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658-3661.
14. Lei F, Xing DM, Xiang L et al. 2003. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract. J Chromatogr B Analyt Technol Biomed Life Sci 796: 189-194.
15. Liu YH, Teng JY, Zheng ZX et al. 2004. Effect of mulberry leaves extract on postprandial blood sugar and activity of alpha-glucosidase. Chin J Clin Rehabil 8: 5896-5897.
16. Maslov DL, Ipatova OM, Abakymova O Yu, Tzvetkova TA, Protorovskii VN. 2002. Investigation of hypoglycemic action of extract from Aronia melanocarpa leaves. Vopr Med Khim 48: 271-277.
17. McGrath T, Latoud C, Arnold ST, Safa AR, Felsted RL, Center MS. 1989. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochem Pharmacol 38: 3611-3619.
18. Mei Y, Qian F, Wei D, Liu J. 2004. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 56: 1307-1314.
19. Mertens-Talcott SU, Percival SS. 2005. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218: 141-151.
20. Mertens-Talcott SU, Talcott ST, Percival SS. 2003. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nut 133: 2669-2674.
21. Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S. 2004. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol (Tokyo) 50: 161-164.
22. Narayanann AA, Geoffroy O, Willingham MC, Re GG, Nixon DW. 1999. p35/p21 (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136: 215-221.
23. Oghami K, Ilieva I, Shiratori K et al. 2005. Anti-inflammatory effects of aronia extract on rat endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 46: 275-281.
24. Ramos S, Alia M, Bravo L, Goya L. 2005. Comparative effects of food-derived polyphenols on the viability and apoptosis of human hepatoma cell line (HepG2). J Agric Food Chem 53: 1271-1280.
25. Saleem A, Husheem M, Härkönen P, Pihlaja K. 2002. Inhibition of cancer cell growth by crude extract and phenolics of Terminalia chebula Retz. fruit. J Ethnopharm 81: 327-336.
26. Sauvaget C, Kasagi F, Waldren CA. 2004. Dietary factors and cancer mortality among atomic-bomb survivors. Mutat Res 551: 145-152.
27. Scalber A, Williamson G. 2000. Dietary intake and bioavailability of polyphenols. J Nutr 130: 2073S-2085S.
28. Skupień K, Oszmiański J. 2004. Comparison of six cultivars of strawberries (Fragaria x ananassa Duch.) grown in northwest Poland. Eur Food Res Tech 219: 66-70.
29. Skupień K, Oszmiański J, Kostrzewa-Nowak D, Tarasiuk J. 2006. In vitro antileukaemic activity of extracts from berry plant leaves against sensitive and multidrug resistant HL60 cells. Cancer Lett 236: 282-291.
30. Tarasiuk J, Stefanska B, Plodzich I et al. 2002. Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells. Br J Pharmacol 135: 1513-1523.
31. Uesato S, Kitagawa Y, Kamishimoto M, Kumagai A, Hori H, Nagasawa H. 2001. Inhibition of green tea catechins against the growth of cancerous human colon and hepatic epithelial cells. Cancer Lett 170: 41-44.